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Background: In interferon-γ-stimulated cells, the dimeric transcription factor STAT1 (signal transducer and activator
of transcription 1) recognizes semi-palindromic motifs in the promoter regions of cytokine-driven target genes
termed GAS (gamma-activated sites). However, the molecular steps that facilitate GAS binding and the subsequent
liberation of STAT1 homodimers from these promoter elements are not well understood.
Results: Using a mutational approach, we identified two critical glutamyl residues within the DNA-binding domain
adjacent to the phosphodiester backbone of DNA which efficiently release phospho-STAT1 from DNA. The release
of STAT1 dimers from DNA enhances transcriptional activity on both interferon-driven reporter and endogenous
target genes. A substitution of either of the two glutamic acid residues broadens the repertoire of putative binding
sites on DNA and enhances binding affinity to GAS sites. However, despite elevated levels of tyrosine
phosphorylation and a prolonged nuclear accumulation period, the STAT1 DNA-binding mutants show a
significantly reduced transcriptional activity upon stimulation of cells with interferon-γ. This reduced transcriptional
response may be explained by the deposition of oligomerized STAT1 molecules outside GAS sites.
Conclusions: Thus, two negatively charged amino acid residues in the DNA-binding domain are engaged in the
liberation of STAT1 from DNA, resulting in a high dissociation rate from non-GAS sites as a key feature of STAT1
signal transduction, which positively regulates cytokine-dependent gene expression probably by preventing
retention at transcriptionally inert sites.Background
A variety of different transcription factors are involved
in the execution of genetic programs, and sequence-
specific DNA binding is a hallmark of transcriptional
regulation. Central to their role as gene-specific tran-
scription factors is their ability to recognize distinct ele-
ments in the promoter regions of responsive genes.
Typically, transcription factors bind with high affinity
and specificity to short motifs of DNA via protein sur-
faces that are complementary to a particular base se-
quence. Although there is often some flexibility in the
nucleotide sequence that is recognized, certain key
bases are crucial for interactions with the DNA-binding* Correspondence: thomas.meyer@med.uni-goettingen.de
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reproduction in any medium, provided the ordomain. The STAT (signal transducer and activator of
transcription) proteins constitute a paradigmatic family
of evolutionary conserved transcription factors with a
modular domain arrangement [1,2]. In mammals, seven
different members of the STAT family are expressed, all
of which consist of three proteolytically separable struc-
tural subunits. An amino-terminal domain is separated
by a protease-sensitive linker peptide from a large core
structure containing the central DNA-binding domain
and a carboxy-terminal transactivation domain [3-6].
The amino-terminal domain of about 130 residues is
folded into a unique hook-shaped architecture that
facilitates cooperative DNA binding through the forma-
tion of tetramers [7-10]. The large core domain encom-
passes several distinct functional domains beginning at
the amino-terminal end with a coiled-coil domain,
which is engaged in protein-protein interactions [11].
The DNA-binding domain displays an immunoglobulind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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phosphorylated STAT dimers to semi-palindromic DNA
sequences termed gamma-activated sites (GAS) [12].
The neighboring linker region consists of a unique all-
alpha helical structure and assists in binding to GAS
elements [13]. The Src homology 2 (SH2) domain med-
iates recruitment to phospho-tyrosyl residues in the
intracellular receptor tails and the formation of
tyrosine-phosphorylated STAT dimers [14,15]. The car-
boxy terminus containing the transactivation domain is
most variable in size and sequence among the different
STAT family members and is frequently subjected to al-
ternative splicing [16].
The STATs are best known for their function as
cytokine-activated transcription factors, which play a
vital role in such diverse processes as growth control,
proliferation, and immune activation [17,18]. The trig-
gering of cytokine receptors initiates a cascade of
phosphorylation steps that causes auto-phosphorylation
of non-covalently attached JAK kinases. The activated
JAK kinases then phosphorylate signature tyrosine resi-
dues in the intracellular receptor tails, thereby, creating
phospho-tyrosine docking sites for the STAT SH2 do-
main [19]. Phosphorylation of a single tyrosine residue
in the STAT carboxy terminus results in a structural
change within the STAT dimer that shifts from an
“antiparallel” to a DNA-bound “parallel” conformation
[20-22]. Tyrosine-phosphorylated STAT enters the nu-
cleus via importin-α/β-mediated transport [23-27] and
binds to semi-palindromic GAS elements in the pro-
moter region of cytokine-responsive genes that contain
the consensus sequence 50-TTC(N)3-4GAA-
03 [3,28,29].
STAT proteins are then dephosphorylated by nuclear
tyrosine phosphatases, some of which have been iden-
tified, such as the Tc45 phosphatase for inactivation of
STAT1 [30-32]. Additionally, unphosphorylated STAT1
molecules translocate constitutively between the cyto-
plasm and the nucleus in both directions through dir-
ect contacts with nucleoporins located in the nuclear
pore complex [33-36].
In contrast to this high-affinity GAS binding, much
less is known about the molecular processes that ensure
the release of STAT1 dimers from DNA. In the follow-
ing, we report on a novel and simple mechanism
that allows STAT1 homodimers to disengage from
DNA. Additionally, we show that a high dissociation
rate from non-specific DNA and a preserved sequence-
specific discrimination between GAS and non-GAS
sites are both required for optimal transcriptional acti-
vation. Moreover, we directly confirm that DNA-bound
STAT1 molecules are protected from dephosphorylation
in vivo, pointing to the essential role of non-specific
DNA binding in the search for cytokine-regulated pro-
moter elements.Results
Mutation of two glutamyl residues in the DNA-binding
domain results in increased tyrosine phosphorylation of
STAT1
In an effort to identify DNA-binding mutants of STAT1
with preserved GAS recognition, we performed a muta-
tional study on the STAT1 molecule and generated nu-
merous point mutants in the DNA-binding domain. A
critical glutamic acid residue at position 411 in the full-
length protein was found to be conserved in STAT1,
STAT2, STAT3 and STAT4 of the human STAT family.
Structural data of the DNA-bound STAT1 dimer
revealed that the carboxyl group of E411 has a distance
of 5.7 Å from the phosphodiester backbone of the co-
crystallized DNA double helix and that there is no other
residue in the STAT1 molecule to prevent its free access
to DNA (Figure 1A). This exposed residue on the sur-
face of the DNA-binding domain was mutated to alanine
and the corresponding mutant was expressed in HeLa
and STAT1-negative U3A cells by transfection with
pSTAT1-GFP. STAT1-E411A was normally expressed
and no indication of structural instability was detected
neither by Western blotting (Figure 1B,C) nor gelshift
experiments (Figure 1D). In response to stimulation of
cells with interferon−γ, the E411A mutant was tyrosine-
phosphorylated (Figure 1B,C) and bound to a single op-
timal GAS site in the M67 probe similar to the wild-type
protein (Figure 1D).
We then performed kinetic studies on tyrosine
dephos-phorylation in IFNγ−prestimulated U3A cells
which were subsequently exposed to 500 nM of the po-
tent ATP-competitive kinase blocker staurosporine [37].
Treatment with the kinase inhibitor resulted in a rapid
and complete dephosphorylation of wild-type STAT1
within 15 min, while the E411A mutant exhibited a
much lower dephosphorylation rate (Figure 1C). More-
over, the ratio of tyrosine-phosphorylated STAT1 to the
total intracellular STAT1 pool, which also contained
unphosphorylated protein, was elevated in the mutant as
compared to its wild-type counterpart (Figure 1B,C).
Similarly, mutation of another glutamic acid residue in
position 421, which also points with its side chain in the
direction of the DNA double helix (Figure 1A), resulted
in defective dephosphorylation and increased DNA-
binding activity (Figure 1E).
When we tested for cooperative DNA binding result-
ing from the ability to form stable tetramers on tandem
GAS sites by means of EMSA analysis, we found no sig-
nificant difference between the wild-type and mutant
STAT1 (Figure 1F). Both variants bound independently
to either GAS site, resulting in both fast migrating
STAT1/DNA complexes containing a single STAT1
dimer and slow migrating complexes with two dimers.
When such complexes were challenged with a 750-fold
Figure 1 (See legend on next page.)
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Figure 1 Substitution of two residues in the DNA-binding domain of STAT1 transcription factor leads to increased tyrosine
phosphorylation and prolonged GAS binding. (A) Localization of critical glutamyl residues 411 and 421 in the DNA-binding domain adjacent
to the DNA molecule. Depicted is a part of the crystal structure of truncated STAT1 bound to DNA [3] with the side chains of E411 and E421
pointing towards the backbone of DNA (on the left; molecular surface, on the right; detail from ribbon diagram with glutamyl residues marked in
yellow). (B) Hyperphosphorylation of STAT1-E411A upon stimulation of cells with increasing concentrations of IFNγ. Equal cell numbers of HeLa
cells expressing either wild-type or mutant STAT1, both tagged with green fluorescent protein (GFP), were exposed to increasing concentrations
of IFNγ for 45 min before tyrosine phosphorylation was tested for in cell lysates. A representative result from a Western blot experiment with a
STAT1-specific phospho-tyrosine antibody (top panel) and the corresponding re-blot after the stripping off of bound immunoreactivity and re-
incubation with pan-STAT1 antibody C-24 (bottom panel) is shown. The upper band on each blot marks recombinant GFP-tagged STAT1,
whereas the lower band corresponds to native STAT1. (C) Decreased tyrosine dephosphorylation of STAT1-E411A upon inhibition of kinase
activity. Equal numbers of U3A cells expressing wild-type or mutant STAT1 were prestimulated for 45 min with 5 ng/ml IFNγ and subsequently
exposed to 500 nM of the kinase blocker staurosporine for the durations indicated. Note that staurosporine treatment resulted in the rapid loss of
tyrosine-phosphorylated STAT1-WT, whereas the mutant was partially resistant to the inactivating staurosporine effect. (D) Prolonged GAS binding
of STAT1-E411A following treatment of IFNγ−prestimulated cells with staurosporine. U3A cells expressing either wild-type or mutant STAT1 were
stimulated for 45 min with IFNγ and thereafter the medium was replaced and the cells treated with 500 nM staurosporine. Cell lysates were
equilibrated with radioactively labeled DNA containing a high-affinity STAT binding site (GAS) before being loaded onto a gel. A representative
gel-shift including two lanes with supershifts using either anti-STAT3 (αS3) or anti-STAT1 (αS1) antibody, respectively, is shown. (E) STAT1-E421K
resists dephosphorylation as determined by gelshift assay using extracts from IFNγ−prestimulated U3A cells that have been exposed to
staurosporine for the indicated times. (F) Tetramer stabilization of the E411A mutant. Extracts from IFNγ−stimulated U3A cells expressing either
wild-type or mutant STAT1 were incubated in vitro with [32P]-labeled DNA containing a tandem GAS site. The reactions were either left
unchallenged (−) or challenged for 30 min with a 750-fold molar excess of a single, unlabeled GAS site (+ competition). At the margin of the
EMSA gel the positions of tetrameric (top arrow) and dimeric (bottom arrow) STAT1 are marked.
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the tetrameric complexes resisted displacement due to
stable tetramerization. In contrast, the dimeric com-
plexes of both wild-type and mutant STAT1 were either
totally or partially displaced, indicative of cooperative
DNA binding. Thus, substitution of either of the two
conserved glutamyl residues in position 411 or 421 of
the full-length STAT1 molecule critically impaired the
continuous dephosphorylation/rephosphorylation cycle
and resulted in elevated and prolonged tyrosine phos-
phorylation levels. However, binding to an optimal GAS
site as well as cooperative DNA binding due to tetramer
stabilization was unaltered.Tyrosine-phosphorylated STAT1-E411A protects
co-expressed endogenous STAT1 from inactivation
The partial insensitivity of STAT1-E411A towards the in-
hibitory effect of staurosporine was independent of the cell
type, as prolonged tyrosine phosphorylation was also
detected in HeLa cells (Figure 2A). Similar to the effect in
U3A cells, stimulation with an equal concentration of
IFNγ resulted in higher levels of tyrosine-phosphorylated
mutant STAT1 as compared to the wild-type. Also in
cytokine-stimulated HeLa cells, the ratio of tyrosine-
phosphorylated STAT1 to the total STAT1 was increased,
indicating that hyperphosphorylation reflects an inherent
property of the mutant. In line with the altered kinetics of
tyrosine phosphorylation, we found that, also in HeLa
cells, DNA-binding activity to the M67 site was enhanced
following 45 min of stimulation with IFNγ (Figure 2B).
Moreover, in the presence of staurosporine the rate of
dephosphorylation was decreased in the point mutant ascompared to the wild-type, thus confirming that the mu-
tant E411A displayed a prolonged state of DNA binding
(Figure 2B).
Interferon-prestimulated HeLa cells expressing en-
dogenous STAT1, in addition to either the GFP fusion of
wild-type STAT1 or its GFP-tagged mutant, were sub-
jected to the inhibitory effect of staurosporine. In cells
expressing STAT1-E411A-GFP, not only did the mutant
phospho-protein resist staurosporine treatment much
better, endogenous STAT1 was also partially insensitive,
as revealed by its prolonged tyrosine phosphorylation
(Figure 2A) and enhanced DNA-binding activity
(Figure 2B). Thus, the presence of the E411A substitu-
tion protects also co-expressed native STAT1 protein
from its rapid inactivation. This finding suggested that
the mutant STAT1 protein interacts with endogenous
STAT1 in a way that impairs access to the inactivating
nuclear phosphatase.Diminished nuclear export of tyrosine-phosphorylated
STAT1-E411A
We then tested whether the nucleocytoplasmic distribu-
tion differed between wild-type and the mutant
(Figure 3A). Cytosolic and nuclear extracts were pre-
pared from either unstimulated or IFNγ−stimulated
HeLa cells expressing STAT1-GFP fusion proteins and
the levels of tyrosine phosphorylation were subsequently
probed by means of Western blotting. It was found that,
in nuclear extracts, the amount of phospho-STAT1 was
significantly higher for mutant STAT1 as compared to
the wild-type, and vice versa, in cytosolic extracts there
was slightly more phosphorylated wild-type protein.
Figure 2 Co-expressed endogenous STAT1 is protected from inactivation through heterodimer formation with STAT1-E411A. (A)
Kinetics of STAT1 dephosphorylation in HeLa cells expressing green fluorescent protein-tagged wild-type or mutant STAT1. Cells were stimulated
with 5 ng/ml IFNγ and subsequently exposed to 500 nM staurosporine for the indicated times. The phosphorylation level was assessed by means
of a Western blot using a phospho-tyrosine-specific STAT1 antibody (top panel). The membrane was then stripped and re-incubated with a
pan-STAT1 antibody (bottom panel). (B) The E411 mutant resists the inhibitory effects of staurosporine and reacts with co-expressed native STAT1
via heterodimerization. HeLa cells expressing either STAT1-WT-GFP or E411A-GFP were stimulated for 45 min with IFNγ before staurosporine was
added for the durations indicated. Whole cell lysates were prepared and incubated in vitro with [32P]-labeled M67 DNA containing a high-affinity
STAT binding site. Resulting STAT1-DNA complexes were separated using an electrophoretic gel shift assay. Note the formation of STAT1-GFP
homodimers (top arrow), heterodimers of GFP-tagged and native STAT1 (middle arrow), as well as homodimers of native STAT1 (bottom arrow).
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cleus was higher when the critical glutamyl residue was
displaced by alanine, resulting in a more pronouncednuclear retention. Again, the amount of endogenous
phospho-STAT1 was higher in HeLa cells expressing the
E411A mutant as compared to its wild-type GFP fusion.
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properties of the mutants by a different approach, we
performed a permeabilized cell transport assay [38]
(Figure 3B). HeLa cells expressing GFP-tagged wild-type
STAT1 or the respective glutamyl mutants were stimu-
lated for 45 min with IFNγ to induce nuclear accumula-
tion of the recombinant fusion proteins. Subsequently,
the cells were either immediately fixed or incubated for
6 min with 50 μg/ml digitonin on ice before fixation.Figure 3 (See legend on next page.)Treatment with digitonin at this concentration select-
ively permeabilized the plasma membrane, thereby, re-
leasing cytoplasmic proteins, while the integrity of the
nuclear envelope remained intact. As expected, stimula-
tion with IFNγ resulted in the nuclear accumulation of
all GFP-tagged STAT1 variants (Figure 3B, top panel).
However, permeabilization by digitonin completely abro-
gated the pre-existing nuclear presence of STAT1-WT-
GFP, while the two mutants remained accumulated in
(See figure on previous page.)
Figure 3 Mutation of E411 results in diminished nuclear export of STAT1. (A) Altered nucleocytoplasmic distribution of the E411A mutant.
HeLa cells expressing GFP-tagged STAT1 variants were either unstimulated (−) or stimulated with IFNγ (+), as indicated. The levels of
phosphorylated STAT1 were probed separately in cytosolic and nuclear extracts by means of Western blotting using a phospho-tyrosine-specific
STAT1 antibody. Similar amounts of endogenous phospho-STAT1 in both transfections were loaded onto the gel (lower band). The concentration
of phosphorylated STAT1-E411A-GFP (upper band) in nuclear extracts (N) exceeded that of the wild-type, whereas, conversely, in cytosolic
extracts (C) there were lower amounts as compared to the wild-type protein. The purity of cytoplasmic/nuclear extracts was assessed by
simultaneous incubation of the blot membrane with anti-ß-tubulin and anti-lamin A antibodies followed by secondary species-specific IRDye
680LT and 800CW antibodies. (B) Reduced nuclear export kinetics of STAT1-E411A and -E421K. HeLa cells expressing fusions of green fluorescent
protein with either wild-type or mutant STAT1 were prestimulated for 45 min with IFNγ to induce nuclear accumulation (top panel) and then
treated for 6 min in the presence of 50 μg/ml digitonin in transport buffer (bottom panel). Fluorescence micrographs of formaldehyde-fixed cells
are shown, demonstrating the amount of nuclear STAT1-GFP and the localization of the corresponding Hoechst-stained nuclei. (C) The E411A
mutation restores defective nuclear accumulation of the STAT1-NES-GFP construct. HeLa cells were transfected with pSTAT1-NES-GFP, which
coded for a transferable nuclear export signal (NES) situated between the cDNAs for full-length STAT1 and GFP. Cells expressing wild-type
STAT1-NES-GFP or the respective E411A variant thereof were either left untreated or stimulated with IFNγ.
Koch et al. BMC Cell Biology 2012, 13:22 Page 7 of 16
http://www.biomedcentral.com/1471-2121/13/22the nucleus (Figure 3B, bottom panel). Thus, the nuclear
export rate of the mutants was critically reduced as
compared to the wild-type protein.
By adding a transferable nuclear export signal (NES) to
GFP-tagged STAT1 [39], we have gathered further evidence
for an altered DNA binding of the mutants. In resting cells,
STAT1-NES-GFP showed a cytoplasmic redistribution as
compared to the nearly pancellular localization of STAT1-
GFP, which resulted from enhanced nuclear export
(Figure 3C). Also in contrast to STAT1-WT, the NES ad-
duct failed to accumulate in the nuclei of interferon-
stimulated cells, because the enhanced nuclear export rate
competed with nuclear retention on DNA. Interestingly,
however, nuclear accumulation was fully restored in the
additional presence of the E411A mutation. This observa-
tion clearly confirms that high-affinity DNA-binding is the
underlying phenotype of the E411A mutant.The mutant E411A exhibits high-affinity GAS binding and
has a broad repertoire of non-optimal binding sites
We now performed experiments that were aimed at elu-
cidating the molecular basis behind the altered activa-
tion/inactivation cycle of the two STAT1 glutamyl
mutants. Putative mechanisms for hyperphosphorylation
of STAT1 variants include diminished nuclear import
due to mutations in either the dimer-specific nuclear im-
port signal or other regions of the STAT1 molecule,
which interact with importin-α, as well as altered bind-
ing kinetics to DNA. STAT1 mutants with impaired nu-
clear import are exposed to the high kinase activity and
comparably low phosphatase activity in the cytosol [33],
and a DNA-binding mutant termed STAT1-dnaplus has
been described, which failed to recognize GAS probes in
gelshift assays [40]. We found that the glutamyl mutants
do not fall into either of these categories, since, upon
cytokine stimulation of cells, the mutants were imported
normally into the nucleus (Figure 3A,B), thus ruling out
defective nuclear accumulation as the cause for theirhyperphosphorylation. Furthermore, the mutants recog-
nized GAS elements in mobility shift assays, clearly
distinguishing them from STAT1-dnaplus, in which
three other residues in the DNA-binding domain were
substituted for positively charged residues (Thr327Arg,
Val426His, Thr427His). The altered DNA-binding kinet-
ics of the glutamyl mutants was evident in competition
experiments employing challenge with excess unlabeled
GAS oligonucleotides (Figure 4A,B). These experiments
clearly revealed that a dramatically reduced dissociation
rate from DNA constitutes their underlying phenotype.
In the mutants, the release from optimal DNA-binding
sites was critically impaired, resulting in a longer half-
life of GAS-bound dimers as compared to wild-type
STAT1. Thus, the stability of preformed protein-DNA
complexes differed significantly between the two mutant
STAT1 proteins and their wild-type counterpart.
In order to compare the sequence requirement for
DNA binding between the E411A mutant and wild-type
STAT1, we used non-optimal GAS elements as molecu-
lar probes in mobility shift assays (Figure 4C). Both the
wild-type and the mutant bound with high affinity to oli-
gonucleotides containing a single GAS site. However,
STAT1-E411A also reacted with a mutated probe which,
due to the exchange of two base pairs, contained no
consensus GAS element. Although binding to this 2x
nonGAS probe was weaker than to either GAS-nonGAS
or tandem GAS oligos, there was a detectable formation
of DNA-bound STAT1 dimers not requiring an intact
GAS site for DNA binding. Thus, in the presence of ex-
cess unlabeled GAS oligos, the E411A mutant bound to
DNA not only with a higher affinity than the wild-type
molecule, but also showed a relaxed sequence require-
ment for interaction with DNA.
In vitro dephosphorylation assays, using whole cell
extracts from reconstituted U3A cells in the presence of
the STAT1-inactivating Tc45 phosphatase, confirmed that
the two glutamyl mutants are indeed DNA-binding
mutants (Figure 4D). It has been shown that DNA-bound
Figure 4 Replacement of glutamyl residues in position 411 or 421 results in STAT1 mutants with a decreased dissociation rate from
DNA and high-affinity binding to non-canonical binding sites. (A) Comparison of the dissociation rates between STAT1-WT and STAT1-E411A
on a DNA fragment containing a single STAT binding site (M67). Whole cell extracts from U3A cells were incubated with radioactively labeled
DNA for 15 min and, subsequently, a 750-fold molar excess of unlabeled DNA was added for the durations indicated before the samples were
loaded onto a polyacrylamide gel. In the first lane, anti-STAT1 antibody C-24 was present in the EMSA reaction for identification of STAT1-DNA
complexes which are marked with an arrow. (B) Similar experiment as in (A), except that U3A cells expressing E421K were used. (C) Sequence
requirements for binding of mutant STAT1 to DNA. Whole cell extracts from U3A cells expressing either STAT1-WT or the E411 mutant were
incubated with various [32P]-labeled DNA molecules containing two single consensus GAS sites (2x GAS), a consensus and mutant GAS site in
tandem arrangement (GAS-nonGAS) or two non-GAS sites (2x non-GAS). Lane 1 is similar to lane 2 except that the reaction additionally
contained STAT1-specific antibody C-24 (αSTAT1). Note that wild-type STAT1 did not bind to 2x non-GAS, while the same DNA fragment exhibits
a weak affinity for STAT1-E411A. The dimeric STAT1-DNA complexes are marked with an arrow. (D) An in vitro dephosphorylation assay shows
that DNA-bound E411A and E421K are protected from Tc45-catalyzed inactivation. Whole cell extracts from reconstituted U3A cells were
incubated with the recombinant Tc45 phosphatase for the indicated times and the reactions were then subsequently probed for phospho-STAT1
levels by means of Western blotting (αp-STAT1). The membrane was stripped and re-incubated with the pan-STAT1 antibody C-24 (αSTAT1).
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from nuclear exit [40], and we report here that the glutamyl
mutants but not the wild-type protein resisted Tc45-
catalyzed inactivation. These experiments collectively dem-
onstrate that there must be a considerable amount of mu-
tant phospho-STAT1 interacting with genomic DNA that
does not participate in nucleocytoplasmic shuttling and
resists inactivation by nuclear phosphatases.A low dissociation rate from DNA results in prolonged
cytokine-induced nuclear accumulation
The experiments presented thus far have shown that
mutation of two critical glutamyl residues in the DNA-
binding domain results in high-affinity DNA binding
and defective tyrosine dephosphorylation of STAT1
upon stimulation of cells with IFNγ. Therefore, we won-
dered whether the resting distribution and the kinetics
Koch et al. BMC Cell Biology 2012, 13:22 Page 9 of 16
http://www.biomedcentral.com/1471-2121/13/22of cytokine-inducible nuclear accumulation differed be-
tween the mutant and wild-type STAT1 variants. For
these experiments, we additionally mutated the glutamyl
acid residues at positions 411 and 421 in positively
charged lysyl residues and found that the resulting two
novel point mutants closely mimicked the corresponding
alanine mutant as described above (data not shown).
The GFP fusion proteins of all three STAT1 variants
(wild-type, E411K, and E421K, respectively) demon-
strated a similar localization in resting HeLa cells,
namely a pancellular distribution with a slightly elevated
cytoplasmic concentration (Figure 5A). Replacement of
the native glutamic acid residues at position 411 and 421
was without effect on the cytokine-induced nuclear ac-
cumulation, since the tyrosine-phosphorylated GFP
fusions were imported normally into the nuclear com-
partment. However, when IFNγ−prestimulated cells were
subsequently treated for 60 min with the kinase inhibitor
staurosporine, a striking difference between the two
point mutants and wild-type STAT1 was detected. In
HeLa cells expressing wild-type STAT1, staurosporine
caused a rapid collapse of nuclear accumulation, while
nuclear localization of the glutamyl mutants persisted
despite the presence of staurosporine. Thus, both point
mutations significantly retarded the nuclear residence
time of STAT1, but did not completely prevent the col-
lapse of nuclear accumulation, since after 120 min of
staurosporine exposure the former resting distribution
of STAT1 was again achieved (data not shown). Thus,
not surprisingly, insensitivity to pharmacological kinase
inactivation resulted not only in elevated levels of
tyrosine-phosphorylated STAT1 (Figures 1 and 2), but
also in a markedly prolonged phase of nuclear accumu-
lation. Additionally, we found that, in the absence of
staurosporine, the nuclear retention time was consider-
ably prolonged for the mutant STAT1 proteins during
IFNγ−induced stimulation (data not shown).
To exclude the possibility that the differential nuclear
accumulation kinetics seen for the glutamyl mutants is
an artefact resulting from the presence of the GFP
domain, we confirmed this finding by means of im-
munocytochemical staining in U3A cells expressing
recombinant, untagged STAT1 (Figure 5B). Similarly to
the GFP adducts expressed in HeLa cells, the respective
glutamyl mutants showed an unaltered resting distribu-
tion and accumulated normally in the nuclei of IFNγ−
stimulated U3A cells. However, after 60 min of
staurosporine addition to the cells, the mutant STAT1
molecules were still predominantly localized in the nu-
cleus, whereas the resting distribution of the wild-type
protein had already been restored at that time point. Fol-
lowing 90 min of staurosporine exposure, the nuclear ac-
cumulation of both mutants had also collapsed,
demonstrating that the DNA-binding mutants were lesssensitive to kinase inhibition. This finding in U3A cells
confirmed that the reduced dephosphorylation rate and
prolonged nuclear accumulation are inherent properties
of the glutamyl mutants, which result directly from their
slow off-rate from DNA.
High-affinity DNA binding crucially impairs transcriptional
responses
The impact of high-affinity DNA binding on gene tran-
scription was next investigated. Reporter gene assays were
performed to assess the consequence of a decreased dis-
sociation rate from DNA on gene expression. Using a luci-
ferase reporter with a synthetic promoter containing three
strong GAS sites separated by 10 bp (3xLy6E), we found
that all STAT1 variants tested displayed transcriptional
responses upon stimulation of reconstituted U3A cells
with IFNγ (Figure 6A). However, reporter gene induction
was significantly repressed in cells expressing either of the
glutamyl mutants as compared to the wild-type protein.
STAT1-E411K displayed the lowest reporter gene acti-
vation of the mutants under investigation, demonstrat-
ing that the transcriptional activity decreased from
wild-type > E411A > E411K (p = 0.049 and p < 0.001,
respectively). Similar results were also obtained for
STAT1-E421K using two reporters containing native
fragments from the ICAM-1 promoter, termed pIC339
and pIC1352 (Figure 6A). Thus, exchange of the nega-
tively charged glutamyl acid residue at position 411 for
either a neutral or positively charged amino acid step-
wise diminished the transcriptional response on a re-
porter gene with a strong cytokine-driven promoter.
We then used real-time RT-PCR assays to probe
the induction of three endogenous IFNγ−responsive
genes in transfected U3A cells. Again, the mutants
failed to reach the transcriptional activity of the wild-
type protein (Figure 6B). While constitutively expressed
recombinant stat1 mRNA was detected in all samples as
expected (p > 0.05), there was a significant reduction in
irf1 mRNA synthesis in U3A cells expressing the E411K
and E421K mutant as compared to wild-type STAT1
(p = 0.029 and p = 0.003, respectively). Induction of
the gbp1 and mig1 gene was also critically impaired or
even completely abolished by replacing either of the
glutamyl residues (for all comparisons p < 0.03).Discussion
Previously, it was shown by in vitro studies using purified
STAT1 that tyrosine-phosphorylated STAT1 dimers
bound to DNA are protected from the inhibitory activity
of nuclear phosphatases and barred from nuclear exit [40].
Although the physiological significance of this finding
remains unclear, it has been suggested that a slow off-rate
from genomic DNA critically compromises the STAT0s
Figure 5 STAT1 DNA-binding mutants with decreased dissociation from DNA exhibit a prolonged nuclear accumulation phase. (A)
Localization of GFP-tagged STAT1 variants in HeLa cells expressing either wild-type or mutant STAT1, in which glutamic acid residues at positions
411 and 421 were substituted for lysine. The cells were left unstimulated (top panel), stimulated with IFNγ for 45 min (middle panel), or
pre-treated with IFNγ and subsequently exposed to 500 nM staurosporine for an additional 60 min (bottom panel). Fluorescence micrographs
demonstrate the intracellular STAT1-GFP distribution before and after cytokine stimulation, as well as the effects of staurosporine treatment.
Corresponding Hoechst-stained nuclei are shown. Note that, in the presence of the kinase blocker staurosporine, both glutamyl mutants
remained in the nuclear compartment, whereas in cells expressing wild-type STAT1 the same treatment resulted in the collapse of STAT1 nuclear
accumulation. (B) Time course of the collapse of nuclear accumulation in U3A cells expressing the indicated untagged STAT1 variants. Cells were
either left untreated or treated for 45 min with IFNγ followed by subsequently exposure to 500 nM staurosporine for 0, 60 and 90 min,
respectively. The nuclei of the methanol-fixed cells were stained with Hoechst dye and the samples processed for immunocytochemical
detection of STAT1 using a pan-STAT1 antibody and appropriate Cy3-labeled secondary antibody.
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number of target genes. The corresponding DNA-binding
mutants of STAT1 created so far display either a
decreased affinity for DNA or a complete failure todiscriminate between GAS and non-GAS elements. Thus,
not surprisingly, both resulted in defective transcriptional
activity [13,41]. However, the behavior of a hypothetical
DNA-binding mutant with preserved GAS recognition
Figure 6 Suppressed transcriptional responses of STAT1 mutants with high-affinity GAS binding. (A) Decreased reporter gene activation
in U3A cells expressing STAT1 DNA-binding mutants as compared to wild-type protein. U3A cells were transiently transfected with expression
plasmids coding for the indicated STAT1 variants, a luciferase reporter construct and a constitutively expressed β-galactosidase gene used for
normalization. The three reporter constructs used in these experiments contained either a triple GAS site from the Ly6E promoter (3xLy6E) or a
339 base pair or 1352 base pair fragment from the native ICAM-1 promoter (pIC339 and pIC1352). On the next day, the cells were either left
untreated (gray columns) or stimulated for 6 hours with 5 ng/ml IFNγ (black columns) before, in whole cell extracts, luciferase luminescence and
ß-galactosidase activity were measured. (B) Reduced activation of three endogenous STAT1 target genes by the E411K and E421K mutants.
RT-PCR assays were performed with U3A cells expressing either STAT1 wild-type, E411K or E421K. Expression levels of the irf1, mig1, gbp1, and for
control stat1 gene before and after 6 hours stimulation with 5 ng/ml IFNγ (gray and black columns, respectively) are shown. Gene induction was
normalized to the expression of the house-keeping gene gapdh. The data are presented as means and standard deviations from at least three
independent experiments. Statistical significance between the groups of IFNγ−stimulated cells expressing the indicated STAT1 variants is marked
by asterisks.
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http://www.biomedcentral.com/1471-2121/13/22and enhanced DNA-binding affinity surpassing that of the
wild-type protein has not been studied so far. It is sur-
mised that such a DNA-binding mutant would be a useful
tool to dissect STAT1 signal transduction in terms of
nucleocytoplasmic shuttling, cytokine-induced nuclear ac-
cumulation, and activation of target genes. As presented
here, we have created such a point mutant which has
allowed us to systematically investigate the transcriptional
consequences of enhanced DNA binding. Using this mu-
tant, we have revealed a simple molecular mechanism that
enables STAT dimers to dissociate from non-target DNA
in order to continue their search for GAS sites. We have
demonstrated that a high off-rate from genomic DNA is
required as a key feature for target gene finding, which
allows for the efficient transmission of extracellular signals
into transcriptional responses.
In an attempt to characterize the biological effects
of increased protein-DNA interactions at a transcrip-
tional level, we performed a mutational study on STAT1
and assessed the resulting mutants for their capability
to bind sequence-specifically to DNA and activate
interferon-responsive target genes. Most of the STAT1
point mutants generated with substitutions in the DNA-
binding domain showed a reduced affinity for DNA and
were, therefore, inappropriate to test the functional con-
sequences of high-affinity DNA binding for gene expres-
sion. However, we identified two single point mutants
that fulfilled our expectations for an enhanced binding
to GAS sites. Replacement of two glutamic acid residues
in the DNA-binding domain, although not interfering
with the recognition of GAS elements, independently
stabilizes preformed STAT1-DNA complexes. The pres-
ence of negatively charged residues at position 411 and
421 is required for the release of STAT1 dimers from
DNA, as their substitution with either alanine or a posi-
tively charged lysyl residue remarkably reduced the dis-
sociation rate from both GAS and GAS-like elements.
The striking finding that enhanced GAS binding is asso-
ciated with a dramatically reduced gene expression in
cytokine-stimulated cells clearly underlines the signifi-
cance of intact nucleocytoplasmic shuttling for full tran-
scriptional activation. Moreover, it suggests that a
limited residence time in the nucleus is an inherent
property of STAT1 signal transduction and, conversely, a
reduced dissociation rate from GAS elements results in
suppressed gene induction.
Available crystallographic data have revealed that the
glutamyl residue 411 does not directly contact specific
nucleotide bases or the sugar-phosphodiester backbone
of DNA, but in the DNA-bound form it has nevertheless
free access to the DNA molecule, suggesting that there
may be some minor structural flexibility within the
STAT1 DNA-binding domain (see Figure 1A). It has
been reported that residue 421 can accept hydrogenbonds from guanine in the minor groove, although the
precise interface between the surface of the STAT1
DNA-binding domain and the DNA double helix in the
proximity to E421 is not known due to the superimpos-
ition of non-equivalent base pairs at these positions [3].
The functional relevance of the two glutamyl residues
can best be regarded as an off-switch to release STAT1
dimers from DNA, so that they become a readily access-
ible substrate for the inactivating nuclear phosphatase.
The presence of a glutamic acid residue with a terminal
carboxyl group adjacent to phosphate groups in the
DNA backbone facilitates the fast disassembly of
STAT1-DNA complexes possibly via electrostatic repul-
sion. Interestingly, these residues are directly engaged in
the discrimination between canonical and non-canonical
binding sites, since its replacement by alanine results in a
mutant with preserved GAS recognition and a broadened
spectrum of potential binding sites (see Figure 4C). This
finding suggests that the repulsive effect on DNA binding
exerted by these residues is independent of the underlying
DNA sequences and occurs at classical GAS, GAS-like or
even non-GAS sites. The native glutamyl residues seem to
facilitate the release of STAT1 dimers from DNA via elec-
trostatic interactions, thereby increasing the number of
STAT1 molecules participating in productive nucleocyto-
plasmic shuttling.
In the wild-type molecule, the fast dissociation from
DNA contributes to the coupling of DNA release and
subsequent tyrosine dephosphorylation to transcriptional
activation. Under conditions of cytokine stimulation the
fast release from DNA ensures that the intracellular con-
centration of tyrosine-phosphorylated STAT1 is always
limited due to the high tyrosine phosphatase activity in
the nucleoplasma. In the DNA-binding mutants E411A/
K and E421K, this coupling between the recruitment to
genomic DNA and their fast dephosphorylation is critic-
ally disturbed, since these mutants are more than the
wild-type protein stacked on genomic DNA in com-
plexes, which may also contain co-expressed native
STAT1 (see Figures 1B and 2A,B). Due to the reduced
number of cycling STAT1 dimers (Figure 3), their
cytokine-induced transcriptional response is substan-
tially limited (Figure 6). The prolonged nuclear residence
time of the glutamyl mutants following cytokine stimula-
tion of cells (Figure 5) appears to directly reflect their
decreased tyrosine dephosphorylation (Figure 4D), suggest-
ing that they are retained in a DNA-bound state at tran-
scriptionally inert genomic loci. Tyrosine-phosphorylated
native STAT1 molecules form heterodimers with the co-
expressed recombinant STAT1 mutants as detected by gel-
shift experiments (Figure 2B), which are integrated into
DNA-bound STAT complexes and protected from fast in-
activation (Figure 2A). Thus, paradoxically, despite their
increased GAS binding and elevated concentration in the
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place, the mutants are nevertheless weaker transcriptional
activators.
Interestingly, by introducing a neutral or a positively
charged functional group at position 411, we generated
a graduated series of STAT1 variants (glutamate > ala-
nine > lysine) with stepwise diminished transcriptional
activity at an artificial reporter gene construct. Thus,
changing the electric charge of this residue permits
interference with gene induction simply by shifting the
amount of STAT1 dimers to a DNA-bound state in
which they are prevented from freely shuttling between
cytoplasm and nucleus. From our experiments, we can-
not conclude whether the impaired transcriptional activ-
ity at native target genes detected for the mutants
results from a diminished exchange rate at a single pro-
moter or merely reflects decreased promoter occupancy
due to predominant deposition at low-affinity DNA-
binding sites. However, we observed that cytokine stimu-
lation leads to high nuclear concentrations of mutant
STAT1, which clearly exceed that of the wild-type pro-
tein (see Figure 3A). This finding suggests that mutant
STAT1 preferentially deposits outside transcriptionally
active sites. In this scenario, a limited number of high-
affinity GAS sites compete with the virtually unlimited
amount of non-GAS sequences within the entire gen-
ome for binding to STAT1. In interferon-stimulated
cells, phospho-STAT dimers retained in the nucleus may
not be exclusively bound to GAS sites, but are addition-
ally recruited to an overwhelming reservoir of unspecific,
low-affinity DNA-binding sites, from which they are
released with very high exchange rates [42]. Interest-
ingly, Lerner and colleagues had previously shown that
STAT3 and glucocorticoid receptor assembled at the α2-
macroglobulin promoter into an enhanceosome for
which continued renewal of both transcription factors
was required for full transcriptional activity [43].
Conclusions
In summary, we present evidence showing that the
presence of two single glutamic acid residues in the DNA-
binding domain adjacent to the DNA backbone sequence-
independently weakens the binding to DNA and is
required for full transcriptional activation of cytokine-
driven target genes. The high dissociation rate from non-
GAS sites ensures that tyrosine-phosphorylated STAT1
dimers can successfully scan genomic DNA for the pres-
ence of specific GAS sites, at which they assemble into
transcriptional active complexes until they are finally
dephosphorylated for nuclear exit. Furthermore, we dem-
onstrate that not a high affinity for GAS sites, but rather
the inherent difference in the off-rates between specific
and non-specific binding sites crucially determines the
function of STAT proteins as transcriptional regulators.Methods
Cell culture
HeLa cells were cultured at 37οC in a humidified 5%
CO2 atmosphere in Quantum 101 medium (PAA La-
boratories) supplemented with 5% fetal calf serum (FCS;
Biochrom), 1% penicillin, and 1% streptomycin. STAT1-
negative U3A cells, originally derived by Müller and col-
leagues [44], were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% FCS, 1% penicillin,
1% streptomycin, and 0.04 μg/ml puromycin. Transfection
was achieved with Lipofectamine plus (Invitrogen) accord-
ing to the manufacturer's recommendation. Twenty-four
hours after transfection, cells were either left unstimulated
or stimulated with 5 ng/ml human IFNγ (Biomol). Subse-
quently, cells were incubated with 500 nM staurosporine
(Sigma) for the time periods indicated.
Plasmids
The plasmid pEGFP-N1-STAT1, which coded for full-
length human STAT1 (amino acids 1–746) fused carboxy-
terminally to green fluorescent protein (GFP), has been
described [45]. For the detection of untagged protein,
STAT1 cDNA was cloned in the expression vector
pcDNA3.1 (Invitrogen). The plasmid pSTAT1-NES-GFP
contained a transferable nuclear export signal (NES) activ-
ity (amino acids 367–427 of STAT1) situated between the
cDNAs for full-length STAT1 and GFP, as described [39].
Mutations in each of these expression vectors were intro-
duced by site-directed point mutagenesis using the Quik-
Change kit from Stratagene, as recommended by the
manufacturer. The native glutamic acid codons at position
411 and 421 were substituted for either alanine or lysine.
All mutations were verified by standard didesoxy termin-
ation DNA sequencing (Seqlab).
Fluorescence microscopy
For direct fluorescence microscopic localization of GFP-
tagged STAT1, transiently transfected cells were treated
as described and subsequently fixed in 3.7% paraformal-
dehyde in phosphate-buffered saline (PBS) for 15 min at
room temperature (RT). Subsequently, nuclei were
stained for 10 min with 5 μg/ml Hoechst 33258 (Sigma)
and the samples were mounted in fluorescence mount-
ing medium (Southern Biotech). Fluorescence micros-
copy was performed using a Leica DM5000B microscope
equipped with appropriate fluorescence filters. Images
were obtained with a CCD camera and further processed
with the Leica QWin software.
Immunocytochemistry
Immunocytochemical detection of untagged STAT1 was
carried out in U3A cells expressing either wild-type or
mutant STAT1. Adherent cells grown on chamber slides
were either left untreated or treated with IFNγ for
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incubated in the presence of 500 nM staurosporine for
an additional 0, 60 or 90 min and then fixed with metha-
nol for 20 min at −20°C. After two washes in PBS, the
cells were permeabilized with 1.0% Triton X-100 in PBS
and non-specific binding was blocked by incubation with
25% FCS/PBS for 45 min at RT. The samples were then
incubated for 45 min with anti-STAT1 antibody C-24
(Santa Cruz) diluted 1:1000 in 25% FCS/PBS. After three
washes in PBS they were incubated with Cy3-conjugated
secondary antibody (Dianova), diluted 1:500 in PBS, for
45 min at RT followed by nuclear staining with Hoechst
dye. Finally, the samples were mounted and images were
captured by fluorescence microscopy.
Digitonization
Adherent HeLa cells expressing GFP-fusion proteins of
STAT1 were stimulated for 45 min with IFNγ to induce
nuclear accumulation of STAT1. Then cells were either
left untreated or permeabilized in the presence of 50 μg/
ml digitonin (Roche) in transport buffer (0.2% Triton X-
100, 10 mM KCl, 1.5 mM MgCl2, 10 mM Hepes, pH 7.4,
1 mM DTT, Complete protease inhibitors from Roche)
for 6 min on ice. After two washes in transport buffer,
cells were fixed for 15 min at RT with 3.7% paraformal-
dehyde in PBS followed by staining with Hoechst dye.
The presence of STAT1-GFP in the nuclei was probed
by means of direct fluorescence microscopy.
In vitro dephosphorylation assay
For in vitro dephoshorylation assays, 10 μl of cytosolic
extracts from U3A cells expressing mutant STAT1 pro-
teins were mixed with a similar volume of dephosphoryla-
tion buffer containing 25 mM Tris–HCl, pH 7.5, 50 mM
KCl, 5 mM EDTA, and 0.3 mg/ml bovine serum albumin.
Then DTT was added to a final concentration of 2 mM
before the samples were incubated at 30°C with 2 U of the
T-cell protein tyrosine phosphatase Tc45 (Biomol Inter-
national, Plymouth, USA) for 0 min, 15 min and 30 min,
respectively. Dephosphorylation reactions were stopped by
adding SDS sample buffer and boiling the samples for
3 min. The amount of tyrosine-phosphorylated STAT1 in
each sample was tested by means of Western blotting.
Western blotting
Cells grown on 6-well dishes were lysed in 30 μl cytoplas-
mic extraction buffer (0.2% Nonidet P40, 10 mM KCl,
1 mM EDTA, 10% glycerol, 20 mM Hepes, pH 7.4,
50 mM NaF, 1 mM vanadate, 1 mM DTT, 0.1 mM PMSF,
Complete protease inhibitors) for 5 min on ice. The
lysates were spun at 16000 g for 10 sec at 4°C. The super-
natants were recentrifuged at 16000 g for 5 min and the
pellets resuspended in 30 μl nuclear extraction buffer
(420 mM KCl, 1 mM EDTA, 20% glycerol, 20 mM Hepes,pH 7.4, 50 mM NaF, 1 mM vanadate, 1 mM DTT,
0.1 mM PMSF, Complete protease inhibitors) for 30 min
on ice and spun for 15 min at 16000 g. The isolated or
combined cytoplasmic and nuclear extraction lysates
were boiled in SDS sample buffer. Proteins were then
resolved by 10% SDS-PAGE and subsequently trans-
ferred to nitrocellulose membranes. The membranes were
incubated with a polyclonal antibody specific for phospho-
STAT1-Tyr701 (Cell Signaling) and then with a horseradish
peroxidase-conjugated secondary antibody (Dako). Bound
immunoreactivity was detected using the enhanced chemi-
luminescence reaction (Pierce). Subsequently, the blots
were stripped for 60 min at 60°C in 2% SDS, 0.7% β-
mercaptoethanol, and 62.5 mM Tris–HCl, pH 6.8. Finally,
the blots were reprobed with the polyclonal pan-STAT1
antibody C-24 followed by incubation with secondary anti-
bodies. The efficiency of nuclear/cytoplasmic fractionation
was assessed by simultaneously incubating blot membranes
with rabbit lamin A (H-102, Santa Cruz) and mouse β-
tubulin antibodies (clone TUB2.1, Sigma) followed by de-
tection with secondary IRDye 680LT and 800CW anti-
bodies visualized on a LI-COR Odyssey imaging machine.
Electrophoretic mobility shift assay (EMSA)
HeLa or U3A cells were transiently transfected with
pSTAT1-GFP or pcDNA3.1-STAT1 coding for either
wild-type or mutant STAT1. The cells were allowed to
recover for 24 hours and then either left unstimulated or
stimulated for 45 min with 5 ng/ml of IFNγ followed by
staurosporine treatment. Cell extracts were prepared as
described above. To prevent dephosphorylation and pro-
teolysis, all cell extracts contained a protease inhibitor
cocktail (Roche), 1 mM vanadate, and 10 mM NaF. Four
microliters of each extract were incubated with 1 ng
[32P]-labeled duplex oligonucleotide probes, generated
by an end-filling reaction using Klenow fragment (New
England Biolabs). The following duplex oligonucleotides
were used (4 bp overhangs at the 50 ends are not
included; the respective antisense oligos are not listed;
GAS sites are underlined): M67, 50-CGACATTTCCCG




CAAC-03. For competition experiments, the EMSA reac-
tions were equilibrated for 15 min at RT before incubation
with a 750-fold molar excess of unlabeled M67 DNA for the
indicated times. In supershift assays, 20 ng of the STAT1-
specific antibody C-24 were preincubated with the shift re-
action for 15 min at RT. The reactions were loaded on a 4%
29:1 acrylamide:bisacrylamide gel at 4°C, as described [45].
STAT1 DNA-binding activity was visualized with a phos-
phoimaging system (BAS-1000, Fujifilm) using the com-
puter programs BAS reader and TINA version 2.08.
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U3A cells grown on 48-well plates were transiently trans-
fected with the following amounts of cDNAs added into a
single well: 250 ng of the respective STAT1 expression
plasmid, 70 ng of a β-galactosidase reporter plasmid (Stra-
tagene), and 200 ng of an IFNγ−sensitive reporter con-
struct. Luciferase reporters contained either a triple Ly6E
STAT-binding site (termed 3xLy6E) or the 50-region of the
human intercellular adhesion molecule 1 (ICAM-1) gene
339 bp and 1352 bp relative to the transcription start site
(termed pIC339 and pIC1352, respectively) [46,47].
Twenty-four hours post-transfection, cells were either left
unstimulated or treated for 6 hours with IFNγ. Whole
cell extracts were prepared and measured for luciferase
(Promega) and β-galactosidase activities. The data were
normalized for the expression of β-galactosidase. For each
STAT1 variant and stimulation mode, six independent
samples were tested and the experiment was repeated at
least three times. Differences in gene activation between
IFNγ−stimulated cells expressing the indicated STAT1
variants were assessed using Student’s t tests and Mann-
Whitney-Wilcoxon tests, where appropriate. Statistical
significance was defined as p < 0.05.
Real-time PCR
The transcriptional activities of wild-type and mutant
STAT1 were assessed by means of real-time PCR. Gene-
specific primers for three endogenous transcripts (irf1,
mig1, and gbp1) as well as for stat1 and gapdh were
designed using Primer 3 software (Applied Biosystems) in
order to amplify fragments of about 200 bp in length. The








CATGACCTCCTGT-03; and STAT1R, 50-TGAATATTC
CCCGACTGAGC-03. Twenty-four hours after transfec-
tion, U3A cells were incubated for an additional 15 hours
with 1% FCS diluted in Dulbecco’s modified Eagle’s
medium. The cells were then either left untreated or sti-
mulated for 6 hours with IFNγ. RNA was isolated with the
peqGold Total RNA kit (Peqlab) and first-strand cDNA
synthesis was performed using the Superscript III kit from
Invitrogen. The real-time PCR reactions were carried out
in a total volume of 25 μl, containing 25 ng cDNA, 70 nM
of each specific primer pair, and 12.5 μl SYBR Green
(Thermo Fisher Scientific). The following protocol was ap-
plied: a denaturation step at 95°C for 15 min, and 45 cycles
of denaturation at 95°C for 15 s, annealing at 55°C for 30 s,
and extension at 72°C for 30 s. Following the finalamplification, a melting curve analysis was run via a
temperature gradient from 60°C to 95°C in 0.5°C increment
steps, fluorescence being measured at each temperature for
a period of 10 s. All reactions were carried out in at least
triplicate for each sample. The relative expression of a tran-
script was normalized to the expression of gapdh as deter-
mined for each sample. Using the Realplex 1.5 software
from Eppendorf, the threshold (Ct) at which the cycle num-
bers were measured was adjusted to areas of exponential
amplification of the traces. The ΔΔCt-method was used to
determine comparative relative expression levels, the for-
mula 2-(ΔCt target - ΔCt reference sample) being applied as
described previously [48]. Statistical analysis was as
described above.
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